Gainers
- Akerna Corp. KERN shares surged 224.4% to close at $49.80 on Wednesday.
- Melinta Therapeutics, Inc. MLNT shares jumped 223.7% to close at $6.41 on Wednesday after the company reported FDA approval of its BAXDELA sNDA for the treatment of community acquired bacterial pneumonia.
- Foresight Autonomous Holdings Ltd. FRSX shares gained 40.4% to close at $1.32 after the company signed a commercial agreement with Elbit Systems for exclusive marketing of its software for the defense market.
- AquaBounty Technologies, Inc. AQB gained 39.9% to close at $3.12.
- Arcturus Therapeutics Holdings Inc ARCT climbed 36.7% to close at $7.90 after the company expanded its research collaboration and licensing agreement with Ultragenyx to develop nucleic acid therapies. The company will receive upfront payments and an equity investment.
- MYOS Corporation MYOS climbed 26.9% to close at $1.70 after the company disclosed positive top-line results from a study evaluating the impact of Fortetropin on the rate of muscle protein synthesis in older men and women.
- Vuzix Corporation VUZI surged 18.6% to close at $4.40.
- Verb Technology Company, Inc. VERB gained 17.3% to close at $2.58.
- Armata Pharmaceuticals, Inc. ARMP shares rose 17.5% to close at $3.36.
- Moxian, Inc. MOXC rose 16.8% to close at $3.20.
- Revolve Group, Inc. RVLV jumped 15% to close at $46.96.
- Savara Inc. SVRA shares gained 13.9% to close at $2.71.
- Axalta Coating Systems Ltd. AXTA gained 13.6% to close at $29.33 after the company announced it has initiated a review of strategic alternatives to maximize shareholder value.
- LSC Communications, Inc. LKSD rose 11% to close at $5.76.
- Tilray, Inc. TLRY rose 10.8% to close at $45.47.
- AVROBIO, Inc. AVRO shares jumped 10.6% to close at $14.61.
- Jabil Inc. JBL gained 10.3% to close at $30.12. Jabil reported in-line earnings for its third quarter, while sales exceeded estimates. The company also issued in-line Q4 guidance.
- Nabors Industries Ltd. NBR shares rose 10.3% to close at $2.4700.
- ATA Inc. ATAI surged 10.2% to close at $2.48.
- Kandi Technologies Group, Inc. KNDI shares rose 10% to close at $5.16.
- CannTrust Holdings Inc CTST gained 8.9% to close at $5.37 after the company announced Wednesday its entrance to the U.S. market, starting in the state of California.
- La-Z-Boy Incorporated LZB rose 8.9% to close at $32.45 after the company reported Q4 EPS and sales results.
- Dyadic International, Inc. DYAI gained 7.6% to close at $6.95.
- Zynex, Inc. ZYXI rose 5.7% to close at $10.38.
- Adobe Inc. ADBE rose 5.2% to close at $291.21 after the company reported better-than-expected Q2 EPS and sales results.
- Nabriva Therapeutics plc NBRV gained 4.8% to close at $2.20 after the company reported submission of FDA Type-A meeting request for intravenous CONTEPO.
- Arch Coal, Inc. ARCH gained 4.4% to close at $94.41 after the company announced it would combine with Peabody Energy for a joint venture.
- United States Steel Corporation X shares rose 4.1% to close at $15.17. US Steel projects Q2 adjusted earnings of $0.40 per share and adjusted EBITDA of $250 million.
Losers
- Jensyn Acquisition Corp. JSYN shares fell 45.7% to close at $5.03. After the closing bell, Jensyn Acquisition reported that the shareholders had approved a merger with peck Electric.
- Legacy Reserves Inc. LGCY dropped 27.6% to close at $0.0790 on Wednesday after the company filed for chapter 11 bankruptcy protection.
- Genocea Biosciences Inc GNCA shares declined 24.8% to close at $3.8500 after the company reported a 10 million shares common stock offering.
- MoneyGram International, Inc. MGI shares dropped 24.5% to close at $2.9300 on Wednesday after climbing 167.59% on Tuesday.
- Cherokee Inc CHKE fell 24.4% to close at $0.6050 after the company reported worse-than-expected Q1 EPS and sales results.
- Sesen Bio Inc SESN shares dipped 19.6% to close at $1.48 on Wednesday. Sesen Bio priced its 20.41 million share offering at $1.47 per share.
- Greenlane Holdings, Inc. GNLN dropped 17.1% to close at $11.00.
- Calithera Biosciences, Inc. CALA fell 13.7% to close at $4.0900 after the company priced its 12.5 million share offering of common stock at $4.00 per share.
- QuickLogic Corporation QUIK fell 13.7% to close at $0.6130 after the company announced the pricing of a 16 million share common stock offering at $0.50 per share, which will result in approximately $8 million in gross proceeds from the offering.
- Intec Pharma Ltd. NTEC dipped 12.6% to close at $4.18.
- Sophiris Bio, Inc. SPHS fell 11.4% to close at $0.8591 after the company received EMA feedback on its Phase 3 prostate cancer trial design. The company expects data from a single phase 3 trial, if successful, will be sufficient to support marketing approval in Europe.
- ContraVir Pharmaceuticals, Inc. CTRV shares fell 10.6% to close at $4.7400.
- Synalloy Corporation SYNL shares fell 10.3% to close at $15.11. Synalloy cut FY2019 guidance from $30.037 million to $21.904 million. Synalloy cut its net income guidance from $9.331 million to $2.779 million.
- China Customer Relations Centers, Inc. CCRC dropped 9.9% to close at $10.37.
- Resonant Inc. RESN dropped 9.8% to close at $2.12.
- MOGU Inc. MOGU shares slipped 9.3% to close at $3.03.
- Zymeworks Inc. ZYME fell 9.2% to close at $18.31. Zymeworks filed prospectus supplements for offering of common shares and pre-funded warrants.
- Spherix Incorporated SPEX dipped 8.9% to close at $2.4600.
- Green Plains Inc. GPRE dropped 8.7% to close at $11.38. Green Plains announced plans to suspend quarterly dividend and priced offering of $105 million aggregate principal amount of 4.00% convertible senior notes due 2024.
- Lonestar Resources US Inc. LONE dropped 8.5% to close at $2.7100.
- GWG Holdings, Inc. GWGH declined 8.4% to close at $8.24.
- YY Inc. YY fell 8% to close at $71.04 after the company reported a proposed offering of US$850 million convertible senior note.
- Global Cord Blood Corporation CO shares declined 7.3% to close at $5.35 after the company reported worse-than-expected Q4 EPS and sales results.
- Jaguar Health, Inc. JAGX dropped 7.3% to close at $5.21. Jaguar Health reported key finding for final canalevia technical section for proposed indication of chemotherapy-induced diarrhea in dogs.
- Cesca Therapeutics Inc. KOOL fell 7.1% to close at $2.88 after rising 11.11% on Tuesday.
- Energizer Holdings, Inc. ENR fell 6.3% to close at $39.20. JP Morgan downgraded Energizer from Neutral to Underweight and lowered the price target from $45 to $36.
- The Lovesac Company LOVE fell 6% to close at $31.30.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in